title: Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
authors.affiliation: Department of Experimental Physiology, Medical School, National & Kapodistrian University of Athens, Goudi-Athens, Greece. mkouts@medscape.com
authors.forename: Michael
authors.initials: M
authors.lastname: Koutsilieris
authors.forename: Theodore
authors.initials: T
authors.lastname: Dimopoulos
authors.forename: Constantine
authors.initials: C
authors.lastname: Milathianakis
authors.forename: John
authors.initials: J
authors.lastname: Bogdanos
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Karamanolakis
authors.forename: Nicholas
authors.initials: N
authors.lastname: Pissimissis
authors.forename: Antonis
authors.initials: A
authors.lastname: Halapas
authors.forename: Peter
authors.initials: P
authors.lastname: Lembessis
authors.forename: Andreas
authors.initials: A
authors.lastname: Papaioannou
authors.forename: Antigone
authors.initials: A
authors.lastname: Sourla
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D003907:Dexamethasone / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013004:Somatostatin / Q000031:analogs & derivatives*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D013004:Somatostatin; D003907:Dexamethasone